skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Biological And Medical Sciences remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Material Type:
Artigo 		Adicionar ao Meu Espaço

BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

RIZOS, Helen ; MENZIES, Alexander M ; HOWIE, Julie ; SAW, Robyn ; THOMPSON, John F ; KEFFORD, Richard F ; SCOLYER, Richard A ; LONG, Georgina V ; PUPO, Gulietta M ; CARLINO, Matteo S ; FUNG, Carina ; HYMAN, Jessica ; HAYDU, Lauren E ; MIJATOV, Branka ; BECKER, Therese M ; BOYD, Suzanah C

Clinical cancer research, 2014-04, Vol.20 (7), p.1965-1977 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
2
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Mahadevan, D ; Chiorean, E.G ; Harris, W.B ; Von Hoff, D.D ; Stejskal-Barnett, A ; Qi, W ; Anthony, S.P ; Younger, A.E ; Rensvold, D.M ; Cordova, F ; Shelton, C.F ; Becker, M.D ; Garlich, J.R ; Durden, D.L ; Ramanathan, R.K

European journal of cancer (1990), 2012-12, Vol.48 (18), p.3319-3327 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids
Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids

Parmentier, Johannes ; Becker, Matthias M.M. ; Heintz, Udo ; Fricker, Gert

International journal of pharmaceutics, 2011-02, Vol.405 (1), p.210-217 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
4
Diagnosis, comorbidities, and management of restless legs syndrome
Diagnosis, comorbidities, and management of restless legs syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnosis, comorbidities, and management of restless legs syndrome

Becker, Philip M. ; Novak, Marta

Current medical research and opinion, 2014-08, Vol.30 (8), p.1441-1460 [Periódico revisado por pares]

Colchester: Informa UK Ltd

Texto completo disponível

Citações Citado por
5
Optimization of Pediatric Rheumatology Therapeutics
Optimization of Pediatric Rheumatology Therapeutics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of Pediatric Rheumatology Therapeutics

Becker, M L

Clinical pharmacology and therapeutics, 2012-04, Vol.91 (4), p.597-606 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor

Wunder, F ; Tinel, H ; Kast, R ; Geerts, A ; Becker, EM ; Kolkhof, P ; Hütter, J ; Ergüden, J ; Härter, M

British journal of pharmacology, 2010-05, Vol.160 (2), p.399-409 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Cytochrome P450 2C9 2 and 3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus
Cytochrome P450 2C9 2 and 3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytochrome P450 2C9 2 and 3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus

Becker, ML ; Visser, LE ; Trienekens, PH ; Hofman, A ; Schaik, RHN ; Stricker, BHCh

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.288-292 [Periódico revisado por pares]

New York, NY: Nature Publishing

Texto completo disponível

Citações Citado por
8
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study

Becker, M O ; Brückner, C ; Scherer, H U ; Wassermann, N ; Humrich, J Y ; Hanitsch, L G ; Schneider, U ; Kawald, A ; Hanke, K ; Burmester, G R ; Riemekasten, G

Annals of the rheumatic diseases, 2011-07, Vol.70 (7), p.1340-1341 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
9
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression
Material Type:
Artigo 		Adicionar ao Meu Espaço

An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression

Becker, Oren M ; Dhanoa, Dale S ; Marantz, Yael ; Chen, Dongli ; Shacham, Sharon ; Cheruku, Srinivasa ; Heifetz, Alexander ; Mohanty, Pradyumna ; Fichman, Merav ; Sharadendu, Anurag ; Nudelman, Raphael ; Kauffman, Michael ; Noiman, Silvia

Journal of medicinal chemistry, 2006-06, Vol.49 (11), p.3116-3135 [Periódico revisado por pares]

Washington, DC: American Chemical Society

Texto completo disponível

Citações Citado por
10
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model

KISKER, Oliver ; BECKER, Christian M ; FOLKMAN, Judah ; PROX, Daniela ; FANNON, Michael ; D'AMATO, Robert ; FLYNN, Evelyn ; FOGLER, William E ; SIM, B. Kim ; ALLRED, Elizabeth N ; PIRIE-SHEPHERD, Steven R

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (20), p.7669-7674 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (574)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (592)
  2. Anais de Congresso  (6)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (35)
  2. 1988Até1993  (72)
  3. 1994Até1999  (135)
  4. 2000Até2006  (188)
  5. Após 2006  (169)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (77)
  2. Alemão  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.